Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Generic drugFirst approved 1993

Nifedipine

Medicare prescription drug cost, prescriptions and prescribers, 2024

$712K

Medicare cost, 2024

Medicare drug plans spent $711,702 on Nifedipine in 2024, for 14,326 prescriptions and refills filled by 5,320 patients. California accounts for the most spending ($138,784, 20% of the total).

Medicare cost, 2024

$712K

-9.5% from 2023

Prescriptions

14K

$49.68 per claim

Patients

5,320

5,580 prescribers

Total spending, 2024

$712K

$133.77 per patient

Questions and answers

How much does Medicare spend on Nifedipine?

Medicare prescription drug plans paid $712K for Nifedipine in 2024, for 14,326 prescriptions and refills to 5,320 patients (down 9.5% from 2023). The average cost per claim was $49.68.

Which state spends the most on Nifedipine?

California had the highest Medicare cost for Nifedipine in 2024: $139K for 2,271 claims, followed by Texas ($59K).

Who prescribes Nifedipine the most?

Swaranjit K Chani, internal medicine in Horse Cave, KY, had the highest Medicare cost for Nifedipine in 2024: 11 claims costing $3,311.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Nifedipine was $712K in 2024, after a high of $823K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Nifedipine, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Swaranjit K Chani Horse Cave, KYInternal Medicine11Under 11$3,311
Paul T Guidry Shreveport, LAInternal Medicine24Under 11$3,226
Daljinder Takhar Pomona, CAFamily Practice17Under 11$2,794
David J Colvin Shell Lake, WIFamily Practice13Under 11$2,186
Marc Lieberman Salinas, CARheumatology14Under 11$2,171
James A Rusch Anthon, IAPhysician Assistant12Under 11$1,993
Yoandra Carralero Miami, FLNurse Practitioner21Under 11$1,927
Henry Roman Bronx, NYInternal Medicine20Under 11$1,819
Darron T Atwood Coleman, TXFamily Practice13Under 11$1,799
Kristoffer T Chin Paramount, CAFamily Practice18Under 11$1,784
Sergey Ayzenberg Brooklyn, NYCardiology19Under 11$1,642
Satinder Saini Crowley, LAInternal Medicine11Under 11$1,560
Sunil H Patel Apple Valley, CANephrology2312$1,512
Steven C Farquhar Deridder, LAInternal Medicine11Under 11$1,493
Daniel N Niknam Inglewood, CAInternal Medicine12Under 11$1,412
Neeraj R Sharma Plano, TXInternal Medicine11Under 11$1,387
Heghine H Harutyunyan Glendale, CANurse Practitioner15Under 11$1,326
Felix S Elpedes Jr. Palm Springs, FLInternal Medicine11Under 11$1,296
Kathryn A Ryan Anchorage, AKFamily Practice12Under 11$1,241
Zachary R Barker Fulton, MOFamily Practice12Under 11$1,127
Molly Garber Cedar Rapids, IANurse Practitioner15Under 11$1,112
Sheryl J Rudolf Park Rapids, MNNurse Practitioner15Under 11$1,000
Karen K Kormis Camp Hill, PAGastroenterology14Under 11$973
Kojo Pobee Dallas, TXInternal Medicine16Under 11$965
Pat F Bass Shreveport, LAInternal Medicine11Under 11$953

Prescriber data by year

YearPrescribersClaimsPatientsCost
20224,95712,8044,794$802K
20235,16113,6744,894$786K
20245,58014,3265,320$712K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Leading Pharma7,951$443K
Avet Pharmaceut6,145$261K
Actavis/TevaTEVA logoTEVA93$4,374
Greenstone LLC.VTRS logoVTRS65$1,830
Chartwell Rx Ll13$728
Major Pharmaceu64$562

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
285
RxNorm concept IDs
1812011, 1812013, 1812015, 198032, 198033
Application numbers
ANDA072781, ANDA075269, ANDA075289, ANDA076070, ANDA077127

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube